Book contents
- Androgens in Gynecological Practice
- Androgens in Gynecological Practice
- Copyright page
- Contents
- About the editors
- Dedication
- Contributors
- Preface
- Section 1 Managing the basics
- 1 Hirsutism: managing the basics
- 2 Alopecia: managing the basics
- 3 Polycystic ovary syndrome: managing the basics
- 4 Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- Section 2 The scientific essentials
- Section 3 Learning from the extremes
- Section 4 The tool kit
- Index
- Plate Section
- References
2 - Alopecia: managing the basics
from Section 1 - Managing the basics
Published online by Cambridge University Press: 05 July 2015
Book contents
- Androgens in Gynecological Practice
- Androgens in Gynecological Practice
- Copyright page
- Contents
- About the editors
- Dedication
- Contributors
- Preface
- Section 1 Managing the basics
- 1 Hirsutism: managing the basics
- 2 Alopecia: managing the basics
- 3 Polycystic ovary syndrome: managing the basics
- 4 Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- Section 2 The scientific essentials
- Section 3 Learning from the extremes
- Section 4 The tool kit
- Index
- Plate Section
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Androgens in Gynecological Practice , pp. 11 - 24Publisher: Cambridge University PressPrint publication year: 2015
References
1.Otberg, N, Finner, AM, Shapiro, J. Androgenetic alopecia. Endocrinol Metab Clin North Am 2007; 36(2): 379–98.CrossRefGoogle ScholarPubMed
2.Paus, R, Cotsarelis, G. The biology of hair follicles. N Engl J Med 1999; 341: 491–7.CrossRefGoogle ScholarPubMed
3.Trüeb, RM. Molecular mechanisms of androgenetic alopecia. Exp Gerontol 2002; 37: 981–90.Google Scholar
4.Randall, VA. Androgens: the main regulator of human hair growth. In: Camacho, FM, Randall, VA, Price, VH, eds. Hair and Its Disorders: Biology, Pathology, and Management. London: Martin Dunitz Ltd, 2000: 69–82.CrossRefGoogle Scholar
6.Marshall, WA, Tanner, JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291–303.Google Scholar
7.Marshall, WA, Tanner, JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970; 45: 13–23.Google Scholar
8.Fritz, MA, Speroff, L. Hirsutism. In: Clinical Gynecologic Endocrinology and Infertility. Philadelphia: Lippincott Williams & Wilkins, 2011: 533–63.Google Scholar
9.Randall, VA. Androgens and human hair growth. Clin Endocrinol 1994; 40: 439–57.CrossRefGoogle ScholarPubMed
10.Hamilton, JB. Male hormone stimulation is a prerequisite and an incitant in common baldness. Am J Anat 1942; 71: 451–80.Google Scholar
12.Messenger, AG. The control of hair growth: an overview. J Invest Dermatol 1993; 101: 4S–9S.CrossRefGoogle ScholarPubMed
13.Hanneken, S, Ritzmann, S, Nothen, M, et al. Androgenetic alopecia: current aspects of a common phenotype. Hautarzt 2003; 54(8): 703–12.Google ScholarPubMed
14.Sawaya, ME. Differences in the mechanisms of androgen action in hair follicles from women and men with androgenetic alopecia. In: Camacho, FM, Randall, VA, Price, VH, eds. Hair and Its Disorders: Biology, Pathology, and Management. London: Martin Dunitz Ltd, 2000: 153–8.Google Scholar
15.Kaufman, KD. Androgen metabolism as it affects hair growth in androgenetic alopecia. Dermatol Clin 1996; 14: 697–711.Google Scholar
16.Bayne, EK, Flanagan, B, Einstein, M, et al. Immunohistochemical localisation of types 1 and 2 5a reductase in human scalp. Br J Dermatol 1999; 141: 481–91.CrossRefGoogle ScholarPubMed
17.Richards, KN, Rashid, RM. Problems in pattern alopecia. J Cosmet Dermatol 2012; 11(2): 131–3.CrossRefGoogle ScholarPubMed
18.El-Samahy, MH, Shaheen, MA, Saddik, DE, et al. Evaluation of androgen receptor gene as a candidate gene in female androgenetic alopecia. Int J Dermatol 2009; 48: 584–7.Google Scholar
19.Norwood, OT. Incidence of female androgenetic alopecia (female pattern alopecia). Dermatol Surg 2001; 27: 53–4.Google ScholarPubMed
20.Birch, MP, Messenger, JF, Messenger, AG. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 2001; 144: 297–304.CrossRefGoogle ScholarPubMed
21.O’Driscoll, JB, Mamtora, H, Higginson, J, et al. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf) 1994; 41: 231–6.Google ScholarPubMed
22.Sawaya, ME. Novel agents for the treatment of alopecia. Semin Cutan Med Surg 1998; 17: 276–83.CrossRefGoogle ScholarPubMed
23.Curtois, M, Loussouarn, G, Horseau, C, et al. Hair cycle and alopecia. Skin Pharm 1994; 7: 84–9.Google Scholar
24.Grino, PB. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology 1990; 126(2): 1165–72.Google Scholar
25.Sinclair, RD, Dawber, RP. Androgenetic alopecia in men and women. Clin Dermatol 2001; 19: 167–78.Google Scholar
26.Kuster, W, Happle, R. The inheritance of common baldness: two B or not two B. J Am Acad Dermatol 1984; 11: 921–6.Google Scholar
27.Norwood, OT, Lehr, B. Female androgenetic alopecia: a separate entity. Dermatol Surg 2000; 26: 679–82.CrossRefGoogle ScholarPubMed
28.Olsen, EA, Messenger, AG, Shapiro, J, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol 2005; 52: 301–11.Google Scholar
30.Ludwig, E. Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex. Br J Dermatol 1977; 97: 247–54.CrossRefGoogle ScholarPubMed
31.Shapiro, J. Clinical practice: hair loss in women. N Engl J Med 2007; 357(16): 1620–30.CrossRefGoogle ScholarPubMed
32.Whiting, DA, Waldstreicher, J, Sanchez, M, et al. Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies. Results of finasteride 1 mg treatment of men and postmenopausal women. J Invest Dermatol Symp Proc 1999; 4: 282–4.Google Scholar
33.Bikle, D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009; 94(1): 26–34.Google Scholar
34.Carey, AH, Chan, KL, Short, F, et al. Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol 1993; 38: 653–8.CrossRefGoogle ScholarPubMed
35.Pittaway, DE. Neoplastic causes of hyperandrogenism. Infertil Reprod Med Clin North Am 1991; 2: 479–94.Google Scholar
36.Kuttenn, F, Couillin, P, Girard, F, et al. Late onset adrenal hyperplasia in hirsutism. N Engl J Med 1985; 313: 224–31.Google Scholar
37.Rogers, NE, Avram, MR. Medical treatments for male and female pattern hair loss. J Am Acad Dermatol 2008; 59(4): 547–66.Google Scholar
38.Lucky, AW, Piacquadio, DJ, Ditre, CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol 2004; 50(4): 541–53.CrossRefGoogle ScholarPubMed
39.Burke, BM, Cunliffe, WJ. Oral spironolactone for female patients with acne, hirsutism or androgenetic alopecia. Br J Dermatol 1985; 112: 124–5.Google Scholar
40.Sinclair, R, Wewerike, M, Jolly, D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol 2005; 152: 466–73.CrossRefGoogle ScholarPubMed
41.Young, R, Sinclair, RD. Continuing medical education: Hirsutes part 2. Australas J Dermatol 1998; 39: 151–67.Google Scholar
42.Yeon, JH, Jung, JY, Choi, JW, et al. 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss. J Eur Acad Dermatol Venereol 2011; 25: 211–14.Google Scholar
43.Shum, KW, Cullen, DR, Messenger, AG. Hair loss in women with hyperandrogenism: four cases responding to finasteride. J Am Acad Dermatol 2002; 47: 733–9.Google Scholar
44.Escobar-Morreale, HF, Lasuncion, MA, Sancho, J. Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity. Fertil Steril 2000; 74: 816–19.Google Scholar
46.O’Driscoll, JB, Mamtora, H, Higginson, J, et al. A prospective study of the prevalence of clear-cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia. Clin Endocrinol (Oxf) 1994; 41: 231–6.Google ScholarPubMed
47.Bulun, SE. Physiology and pathology of the female reproductive axis. In: Melmed, S, Polonsky, KS, Larsen, PR, et al, eds. Williams Textbook of Endocrinology. Philadelphia: Elsevier Saunders, 2011: 581–660.Google Scholar
48.Martin, KA, Chang, RJ, Ehrmann, DA, et al. Evaluation and treatment of hirsutism in premenopausal women: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2008; 93: 1105–20.CrossRefGoogle ScholarPubMed
49.Blume-Peytavi, U, Hahn, S. Medical treatment of hirsutism. Dermatol Ther 2008; 21(5): 329–39.CrossRefGoogle ScholarPubMed
50.Hamzavi, I, Tan, E, Shapiro, J, et al. A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women. J Am Acad Dermatol 2007; 57: 54–9.Google Scholar